Krogan Q&A: Collaboration and the new era of science

School of Medicine Department of Cellular and Molecular Pharmacology faculty member Nevan Krogan, PhD, spoke with Nooshin Navidi Latour, MA, communications director at UCSF Precision Medicine about the challenges academic research faces when it comes to breaking down silos and about how facilitating collaboration is the solution.

Upon its inception in March 2016, Krogan became director of the School of Pharmacy’s Quantitative Biosciences Institute (QBI), where, he says, “the big focus is on connections—connecting technologies, connecting different disease areas, and connecting people, not just at UCSF, not just in the United States, but around the world. Not just between scientists, but between scientists and non-scientists.”

“Before the pandemic, QBI…had set a really strong foundation with our worldwide collaborative network. When the pandemic hit, we could just pick up the phone and get moving quickly. We could see how fast science can move when we didn't really care about the reward structure. Everybody just collaborated.... Now as the dust settles on the pandemic, what can we learn?”


Spotlight: Nevan Krogan, Breaking Down Silos, The New Era of Science


About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.